Mixed messages on systemic therapies for diabetic retinopathy - Authors' reply

The Lancet

Volumn 376, Issue 9751, 2010, Pages 1462-

  Ismail Beigi, F ^a   Craven, T ^a   Genuth, S ^a   Hramiack, I ^a   Karl, D ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FENOFIBRATE;

ALBUMINURIA; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PRIORITY JOURNAL; RATING SCALE;

EID: 78049510607     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61986-1     Document Type: Letter

References (3)

1. The ACCORD Study Group and ACCORD Eye Study Group Effects of medical therapies on retinopathy progression in type 2 diabetes N Engl J Med 363 2010 233 244
2. HN Ginsberg, MB Elam, LC Lovato Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
3. WC Cushman, GW Evans, RP Byington Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585